Start with the evidence currently retained.
One glance at identity, filing chronology and source layers before opening the full issuer dossier.
Official reference points for this company.
This page distinguishes the earliest retained official filing from an issuer’s first public trading or initial quotation date. Missing history is not a conclusion about the issuer.
RWB Health Inc.
Business context
Official filing overview: We are engaged in the business of providing CBD Cannabinoid based products to the North American and European markets both retail and wholesale.
Newly detected public-record events
Events first captured by this monitoring workflow for this CIK. Open the source and the filing brief before making any legal, diligence or transaction conclusion.
- S-1/ARWB Health Inc.Official source →
- S-1/ARWB Health Inc.Official source →
- S-1/ARWB Health Inc.Official source →
Evidence chain for this issuer
Built from 3 captured SEC filing nodes, from 2026-03-26 through 2026-04-23. It shows what has been observed in the record and what still needs independent verification.
- Identity anchorCIK 0002107166 · issuer name carried from the SEC filing history
- Registration entryNo initial S-1 / F-1 is in the captured record
- Amendment trail3 amendments captured
- Effectiveness / prospectusNo EFFECT or 424B is in the captured record
- Ongoing record watchLatest captured form: S-1/A on 2026-04-23
CIK and issuer name are linked to the captured SEC filing sequence.
Not present in the currently captured SEC record. This is not a negative finding.
3 amendments captured for comparison.
Not present in the currently captured SEC record. This is not a negative finding.
Verification queue
- Confirm current legal entity, officers, directors and control from the controlling filing and corporate records.
- Review capitalization, transfer-agent information and any beneficial-ownership questions through the client’s qualified advisers.
- Compare material business, financing and risk disclosure changes in the official source documents.
Source boundary
Forms captured: S-1/A. This is an evidence map, not a safety rating, shell determination, legal opinion, valuation or transaction recommendation. Absence from a captured source is never proof that a fact does not exist.
Open Evidence Snapshot →Need a documented diligence trail?
Use this issuer dossier as the starting evidence layer. A defined scope can package the official filing history, public company actions and questions for your independently retained advisers to review.
What changed in the filing path
Relationship cues are generated from the order and form type of retained official filings. They are not a clause-by-clause document redline; verify terms in the linked source.
- Registration pathS-1/A
Amendment form captured; no prior same-lane filing is retained in this timeline
Open official filing →
Comparable filing terms
Machine comparison found 1 retained filing pair with comparable term-text differences. These are extracted text windows, not a definitive legal or economic comparison. Official filings control.
- S-1/A · 2026-04-13Compared with S-1/A · 2026-03-26
Offer size / shares
Earlier extract: mum purchase requirement. The Issuer: RWB Health Inc. Securities Being Offered: 3,000,000 shares of common stock. Shares Outstanding Prior to Offering: 3,500,000 restricted shares of common stock. Shares Outstanding after Offering: 6,500,000 shares of common s
Later extract: epart of the Registration Statement and Outside Front Cover Page of Prospectus. 3,000,000 SHARES OF COMMON STOCK This is the initial offering of common stock of RWB HEALTH INC. and no public market currently exists for the securities being offered. We are offe
Offering price
Earlier extract: TABLE OF CONTENTS PROSPECTUS SUMMARY 3 RISK FACTORS 6 USE OF PROCEEDS 14 DETERMINATION OF OFFERING PRICE 14 DILUTION 15 INFORMATION WITH RESPECT TO THE REGISTRANT 20 AVAILABLE INFORMATION 22 LEGAL PROCEEDINGS 23 DIRECTORS, EXECUTIVE OFFICERS, PROMOTER AND CONT
Later extract: TABLE OF CONTENTS PROSPECTUS SUMMARY 4 RISK FACTORS 7 USE OF PROCEEDS 15 DETERMINATION OF OFFERING PRICE 15 DILUTION 16 INFORMATION WITH RESPECT TO THE REGISTRANT 21 AVAILABLE INFORMATION 23 LEGAL PROCEEDINGS 24 DIRECTORS, EXECUTIVE OFFICERS, PROMOTER AND CONT
Use of proceeds
Earlier extract: ant to Section 8(a), may determine. TABLE OF CONTENTS PROSPECTUS SUMMARY 3 RISK FACTORS 6 USE OF PROCEEDS 14 DETERMINATION OF OFFERING PRICE 14 DILUTION 15 INFORMATION WITH RESPECT TO THE REGISTRANT 20 AVAILABLE INFORMATION 22 LEGAL PROCEEDINGS 23 DIRECTORS, E
Later extract: ant to Section 8(a), may determine. TABLE OF CONTENTS PROSPECTUS SUMMARY 4 RISK FACTORS 7 USE OF PROCEEDS 15 DETERMINATION OF OFFERING PRICE 15 DILUTION 16 INFORMATION WITH RESPECT TO THE REGISTRANT 21 AVAILABLE INFORMATION 23 LEGAL PROCEEDINGS 24 DIRECTORS, E
Open later official filing →Underwriting arrangement
Earlier extract: is is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. 2 Table of Contents PROSPECTUS SUMMARY AS USED IN THIS PROSPECTUS, UNLESS THE CONTEXT OTHERWISE
Later extract: is is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. 2 Table of Contents Part 1 - INFORMATION REQUIRED IN PROSPECTUS Item 1. Forepart of the Registr
Save a dated issuer evidence record.
When this company needs to move from a live review into a client, counsel, broker-dealer or internal file, generate the current source-linked Evidence Snapshot.
Official filing chronology · change cues · printable HTML · CSV source indexResearch routes for this issuer
Use the issuer chronology for the record. These focused indexes make it easier to compare the same official filing type across the monitored OTC universe.
What to review next
Rules are applied to retained SEC filing types in this issuer record. They prioritize reading work; they are not ratings or conclusions.
- CRITICALEFFECT2026-05-08 · form-type review cueSEC source →
- WATCHS-1/A2026-04-23 · form-type review cueSEC source →
- WATCHS-1/A2026-04-13 · form-type review cueSEC source →
- WATCHS-1/A2026-03-26 · form-type review cueSEC source →
- WATCHS-12026-02-20 · form-type review cueSEC source →
Official filing timeline
- S-1/A · official filing
RWB Health Inc.
- S-1/A · official filing
RWB Health Inc.
- S-1/A · official filing
RWB Health Inc.
Need a dated issuer evidence chain?
Generate a source-linked Shell Readiness File for first-pass internal screening. It organizes public records; it does not determine shell status or transaction feasibility.
Verify beyond this monitor.
These links open third-party official sources. They do not imply a match, a current quotation, a legal finding, or an OTC Markets data license.
What this dossier currently contains.
“Not retained” means this monitor does not currently hold a matching record in the named source layer. It does not establish absence, quotation status, compliance status, or issuer quality.
Retained SEC record, including historical submissions.
Recent filings are retained from the SEC submissions index. On dossier visits, the monitor also checks the SEC’s older submission archive in the background. This is a filing-history view—not a quotation, trading, financing-close or capitalization record.
Historical archive check pending retry. 2026-09-19 11:25 UTC. “Not retained” or a low count means this monitor has not stored a matching filing; it does not establish absence of a filing or issuer activity.
Official release-title candidates, not a risk label.
The SEC describes Litigation Releases as records concerning civil actions brought by the Commission in federal court. This monitor checks only the SEC’s official release feed and only surfaces a strict company-name title candidate for human review.
Issuer name is too short for conservative automatic matching. Feed cache: 2026-09-19 07:15 UTC.
A candidate does not confirm that this issuer is a respondent, defendant, affiliate, currently subject to an action, or associated with a filing. Names can overlap or change. Open the official SEC source and independently verify legal identity, entity status and context.
Names retained under this CIK.
These names come from the SEC submissions record and are useful identity clues when reviewing older filings or release titles. They do not independently prove a merger, reverse merger, ticker change, transaction date or continuity of business.
- RWB Health Inc.Current SEC submission name
Latest retained dollar facts, with period context.
Values come directly from SEC Companyfacts. Different facts can have different reporting periods or filing dates, so they are not combined into ratios or performance conclusions.
Source check: 2026-09-19 05:24 UTC. “Not retained” means no compatible USD fact was stored by this monitor; it does not establish that the company has no revenue, cash, assets, filings, operations or reporting obligation. Open the SEC filing for full context.
Source-bound professional discussion.
Research Notes keep observations, questions and correction requests attached to the official-record workflow. This discussion layer is not a recommendation, valuation, legal conclusion or trading venue.
Prepare a source-led update from this record.
Open the Newsroom Kit with this CIK already selected. It creates editable public-record drafts, a source citation and a review handoff—never a published release or a statement of issuer approval.
Company press releases
此区域仅收录公司新闻稿、公司公告或官网发布内容,不重复 SEC 申报动态。当前可先通过 OTC Markets 公司新闻页查看原文。
打开 OTC Markets 新闻原文 ↗Company press releases
公司新闻稿与公告将按公开来源归档;SEC 申报动态继续保留在原有 SEC 模块。
查看新闻稿入口 →Company press releases
Source available · Last updated: 2026/9/19 11:15:27
No press releases cached for this company.
View all press releases →